View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
December 8, 2017updated 07 Dec 2017 9:38pm

M&As this week: CVS Health Corporation, NeuroSearch

CVS Health Corporation (CVS) has agreed to acquire the entire outstanding shares of Aetna for a total consideration of $77bn.

CVS Health Corporation (CVS) has agreed to acquire the entire outstanding shares of Aetna for a total consideration of $77bn.

The shareholders of the target company will be paid $145 a share in cash and issued 0.8378 CVS shares for each Aetna share held. The target company shareholders will hold 22% of the merged company, while the remaining will be held by the acquirer company shareholders.

The transaction will integrate the expertise of CVS and Aetna to redefine consumer healthcare experience and build a healthcare platform for individuals.

“NeuroSearch has announced its intention to be sold to a potential buyer in 2018.”

NeuroSearch has announced its intention to be sold to a potential buyer in 2018.

Based in Denmark, NeuroSearch is a biotechnology company involved in developing pharmaceuticals for the treatment of diseases and disorders.

The firm plans for voluntary liquidation in case it does not secure a satisfactory bid.

The net proceeds of liquidation are intended to be distributed to the shareholders.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology